AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $283,795 | +23.8% | 10,021 | +0.4% | 0.00% | – |
Q1 2023 | $229,241 | -19.0% | 9,980 | -0.9% | 0.00% | – |
Q4 2022 | $282,850 | +23.5% | 10,073 | +24.8% | 0.00% | – |
Q3 2022 | $229,000 | -95.1% | 8,070 | -92.1% | 0.00% | -100.0% |
Q4 2018 | $4,689,000 | +5.9% | 101,700 | +77.2% | 0.00% | +50.0% |
Q3 2018 | $4,427,000 | -8.4% | 57,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $4,835,000 | +3.0% | 57,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $4,694,000 | +31.4% | 57,400 | -8.2% | 0.00% | 0.0% |
Q4 2017 | $3,573,000 | -17.7% | 62,500 | -3.8% | 0.00% | 0.0% |
Q3 2017 | $4,339,000 | -80.3% | 65,000 | -81.9% | 0.00% | -80.0% |
Q3 2014 | $22,000,000 | +10.0% | 358,600 | -17.8% | 0.01% | +11.1% |
Q2 2014 | $20,000,000 | +6.8% | 436,500 | -8.7% | 0.01% | 0.0% |
Q1 2014 | $18,725,000 | +55.9% | 478,300 | -4.6% | 0.01% | +50.0% |
Q4 2013 | $12,011,000 | -31.7% | 501,500 | -20.3% | 0.01% | -33.3% |
Q3 2013 | $17,598,000 | – | 629,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |